Trifluridine/tipiracil hydrochloride mixture
TAS-102 is an oral combination drug for research, composed of trifluridine and tipiracil hydrochloride in a 2:1 molar ratio. It is used in oncology research to study its antimetabolite and thymidine phosphorylase inhibitory effects in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
733030-01-8
Product Name Alternative
DNASynthesis, DNA, DNA Synthesis, DNA/RNA Synthesis, Analog, antitumor, FTD, Inhibitor, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Nucleoside Antimetabolite, nucleoside, oral, inhibit, Thymidylate Synthase, RNA Synthesis, RNASynthesis, TAS 102, TAS102, TAS-102, TPI, Trifluridine/tipiracil hydrochloride mixture, Trifluridine-tipiracil hydrochloride mixture
Field of Research
Cell Biology, Molecular Biology, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:100 mg/mL (114.74 mM) ; H2O:50 mg/mL (57.37 mM) ; Ethanol:100 mg/mL (114.74 mM)
Smiles
Cl.Clc1c (CN2CCCC2=N) [nH]c (=O) [nH]c1=O.OC[C@H]1O[C@H] (C[C@@H]1O) n1cc (c (=O) [nH]c1=O) C (F) (F) F.OC[C@H]1O[C@H] (C[C@@H]1O) n1cc (c (=O) [nH]c1=O) C (F) (F) F
Molecular Formula
C29H34Cl2F6N8O12
Molecular Weight
871.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681102-500 1x 500 µL
Cdc20 (CDC20/1102), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471992-100 1x 100 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1992), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 